argenx raises $1.1 billion in gross proceeds in a global offering

argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced the pricing of a global offering of ordinary shares, which may be represented by American Depository Shares.

Scroll to Top